Nike, DJT Rise; Corcept Falls
On this episode of stock movers: Nike (NKE) shares rose on Wednesday after CEO Elliott Hill reported the purchase of about $1 million in shares. Corcept (CORT) shares fell after US regulators rejected the company’s drug to treat a form of high blood pressure. The Food and Drug Administration “could not arrive at a favorable benefit-risk assessment” for the company’s drug, relacorilant, without more evidence of its effectiveness, the Redwood City, California-based company said in a statement Wednesday. Trump Media and Technology Group (DJT) shares rose on news the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.